ReiThera Srl, The Ragon Institute and IAVI Announce Collaboration to Advance Highly Networked T Cell HIV Vaccine Candidate Towards Phase I Clinical Evaluation
January 22, 2024 08:00 ET
|
Reithera
Novel HIV vaccine candidate based on Gorilla adenoviral vector (GRAd-HIV) funded by the Bill & Melinda Gates Foundation to alleviate the disease burden and improve the lives of the millions who...
1-Decene Market worth $798 million by 2025 Globally, at a CAGR of 6.7% says MarketsandMarkets™
January 22, 2024 08:00 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The global 1-Decene Market size is estimated to be USD 576 million in 2020 and is expected to reach USD 798 million by 2025, at a CAGR 6.7% during the...
Point Blank Enterprises now offers its latest Point Blank Duty Gear line
January 22, 2024 08:00 ET
|
Point Blank Enterprises
POMPANO BEACH, Fla., Jan. 22, 2024 (GLOBE NEWSWIRE) -- Point Blank Enterprises (“Point Blank” or “PBE”), the worldwide leader in the production of soft and hard body armor and related protective...
Taysha Gene Therapies Announces Poster Presentation on TSHA-102 in Rett Syndrome at Upcoming British Paediatric Neurology Association 2024 Annual Conference
January 22, 2024 08:00 ET
|
Taysha Gene Therapies, Inc.
DALLAS, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the...
SANUWAVE Announces Special Meeting of Stockholders to Vote on Business Combination with SEP Acquisition Corp. (Nasdaq: SEPA)
January 22, 2024 07:59 ET
|
SANUWAVE Health, Inc.
EDEN PRAIRIE, MN, Jan. 22, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (the "Company" or "SANUWAVE”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound...
Ferrari N.v.: Periodic Report on the Buyback Program
January 22, 2024 07:59 ET
|
Ferrari N.V.
ranello (Italy), January 22, 2024 – Ferrari N.V. (NYSE/EXM: RACE) (“Ferrari” or the “Company”) informs that the Company has purchased, under the Euro 350 million share buyback program announced on...
60 Degrees Pharma Plans Pivotal Babesiosis Study with Tafenoquine Following Jan 17 FDA Meeting
January 22, 2024 07:59 ET
|
Sixty Degrees Pharmaceuticals
Post-FDA meeting, 60 Degrees Pharma plans pivotal study of tafenoquine in hospitalized babesiosis patients, aiming to start in summer 2024. #biotech #SXTP
Next-generation Solar Cell Market Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023-2031
January 22, 2024 07:58 ET
|
Research and Markets
Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Next-generation Solar Cell Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and...
Digital Breast Tomosynthesis (DBT) Equipment Market Share to Surpass USD 6.83 billion by 2030 | Analysis by Persistence Market Research
January 22, 2024 07:56 ET
|
Persistence Market Research
New York, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The global digital breast tomosynthesis (DBT) equipment market is expected to grow at a rate of 13.9%, reaching a value of US$6.83 billion by 2030 from...
Butylated Hydroxytoluene (BHT) Market Size to Hit $1.60 Billion, Globally, by 2030 | Exclusive Report by Persistence Market Research
January 22, 2024 07:56 ET
|
Persistence Market Research
New York, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The global butylated hydroxytoluene (BHT) market is expected to grow at a rate of 6.1%, reaching a value of US$1.60 billion by 2030 from US$0.26 billion...
- July 31, 2024 05:46 ET Data Center GPU (Graphics Processing Units) Global Strategic Analysis Report 2024: Market to Reach $92 Billion by 2030 - Focus on Energy Efficiency and Sustainability Strengthens Business Case
- July 31, 2024 05:38 ET Smart Fabrics Markets and Global Strategic Business Report, 2024-2030 - Expansion of IoT in Consumer Products Boosting Demand for Connected Fabrics